Pre_GI: SWBIT SVG BLASTN

Query: NC_011595:3015895 Acinetobacter baumannii AB307-0294, complete genome

Lineage: Acinetobacter baumannii; Acinetobacter; Moraxellaceae; Pseudomonadales; Proteobacteria; Bacteria

General Information: Acinetobacter baumannii AB307-0294 was isolated from the blood of a hospitalized patient in Buffalo, NY, USA. This is a multi-drug resistant strain. Acinetobacter baumannii is commonly isolated from the hospital environment and hospitalized patients. It is an aquatic organism, and is often cultured from liquid medical samples such as respiratory secretions, wounds, and urine. Acinetobacter also colonizes irrigating solutions and intravenous solutions. Although it has low virulence, it is capable of causing infection. Most isolates recovered from patients represent colonization rather than infection. When infections do occur, they usually occur in the blood, or in organs with a high fluid content, such as the lungs or urinary tract. Infections by this organism are becoming increasingly problematic due to the high number of resistance genes found in clinical isolates. Some strains are now resistant to all known antibiotics. Most of these genes appear to have been transferred horizontally from other organisms.

- Sequence; - BLASTN hit (Low score = Light, High score = Dark)
- hypothetical protein; - cds: hover for description

BLASTN Alignment.txt

Subject: NC_014259:3369000 Acinetobacter sp. DR1 chromosome, complete genome

Lineage: Acinetobacter oleivorans; Acinetobacter; Moraxellaceae; Pseudomonadales; Proteobacteria; Bacteria

General Information: This strain is capable of degrading paraffin, n-hexadecane, diesel. Acinetobacter sp. DR1 is a diesel degrader Gram-negative bacterium isolated from the soil of rice paddies in Soth Korea. They are found in many different habitats, including soil, water, and sewage, as well as in a variety of foodstuffs. They are also members of the normal microflora of human skin, and have been implicated as a presumed causative or contributory agent of numerous nosocomial (in-hospital) infections, especially those in immunocompromised individuals. Due to their genomic versatility, these bacteria are highly adaptive to treatment with various antibiotic reagents.